Cohort Analysis
Several comprehensive cohorts with complete clinic-pathological and follow up information are available through the TMA facility, YPTS. Analysis of biomarkers of interest on these cohorts offer a unique opportunity to study prognostic and in some cohorts predictive value of the target of interest in a high through put, objective and automated manner.
Shown here is the analysis of ESR1 in a tamoxifen treated breast cancer cohort.
